Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.

Morten Hasselstrøm JensenSimon Lebech CichoszPeter GustenhoffAmar NikontovicOle HejlesenPeter Vestergaard

Published in: PloS one (2022)

Our results indicate that patients with type 1 diabetes in poor glycaemic control from Region North Denmark in general benefit from using isCGM with a sustained 24-month improvement in HbA1c, but the effect on HbA1c may be less pronounced for older patients.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
cardiovascular disease
tertiary care
peritoneal dialysis
insulin resistance
metabolic syndrome
patient reported outcomes
patient reported